Introduction {#sec1}
============

There is some controversy as to who (and when) exactly performed the first laparoscopic splenectomy (LS) \[[@cit0001]\]. The year 1991 and the author Carroll *et al.* \[[@cit0002]\] or (more likely) Delaitre and Maignien \[[@cit0003], [@cit0004]\] are most frequently mentioned. Anyway, this procedure has been available for more than a quarter of a century and has replaced in most centers traditional, open splenectomy (OP). Even though many authors share the opinion about the "standardized approach" there are some important differences regarding the surgical technique. Some reports concentrate mostly on the access to the peritoneal cavity, discussing differences between 4-port laparoscopy, SILS, Hand-assisted laparoscopic surgery (HALS) etc. However, regarding postoperative course this seems to be of lesser importance than the technique of dissection and control of splenic vascular supply. Throughout the 20 years of our experience, with more than 500 laparoscopic operations of the spleen, we have attempted to use several different techniques. However, two methods, differing in approach to the splenic vessels, referred to as "vessels first" and "hilar transection", have been used most frequently.

Aim {#sec2}
===

The aim of the study was to evaluate the outcomes of LS performed with two different approaches: "vessels first" and "hilar transection".

Material and methods {#sec3}
====================

Design {#sec3.1}
------

This observational study design was based on retrospective analysis of prospectively collected data in all consecutive patients undergoing laparoscopic operations of the spleen (total splenectomy as well as spleen-sparing procedures) in a tertiary referral university surgical center in 1998--2017. Inclusion criteria were: elective total splenectomy performed for hematological disorders, pure laparoscopic or single incision approach, "vessels first" or "hilar transection" technique for control of the vascular supply. We excluded patients with splenic trauma, initially submitted to open surgery, stapled transection of the splenic hilum, partial resections of the spleen and other spleen-preserving procedures. Patients were divided by operative technique used during the operation and analyzed in two groups: group 1 ("vessels first"), and group 2 ("hilar transection").

Outcomes {#sec3.2}
--------

The primary outcomes were related to the assessment of the course of the procedure and included operative time, conversion rate, intraoperative blood loss and intraoperative adverse events/complications. Operative time was measured from skin incision to closure. The intraoperative blood loss was measured from the amount of blood aspirated in the suction machine. Intraoperative adverse events/complications were defined as any iatrogenic harmful event occurring during the operation, which had not derived from the standard technique. Intraoperative blood loss equal to or greater than 500 ml was considered to be a hemorrhage and was included as an intraoperative complication, because losing less than one unit of blood (≈500 ml) usually does not negatively affect the condition of the patient and does not lead to hypovolemia and hemorrhagic shock \[[@cit0005], [@cit0006]\]. Indications for transfusion were: hemorrhagic shock, hemoglobin ≤ 6 g% or 6--8 g% in case of evidence for limited compensation and risk factors (e.g. coronary heart disease, systolic heart failure, insufficient cerebral vascular flow) or presence of the following symptoms: tachycardia, hypotension, acute coronary ischemia in ECG, acidosis \[[@cit0007]\].

The secondary outcomes included parameters of the postoperative course: 30-day postoperative morbidity (graded with Clavien-Dindo classification \[[@cit0008]\]), mortality, reoperations and length of stay. W paid special attention to complications that might have resulted directly from the operative technique, i.e. related to potential injury of the pancreatic tail. We defined reoperations as a subsequent operation performed due to a postoperative complication after LS. The length of stay (LOS) was measured from the admission day until discharge.

Operative technique {#sec3.3}
-------------------

In our department the primary choice of the operative access to the peritoneal cavity during LS is a laparoscopic 4-port technique. During the study period seven patients were operated on through a single incision, but after a feasibility study this technique was abandoned \[[@cit0009], [@cit0010]\]. Hand-assisted laparoscopic surgery was used only in 5 cases as an alternative to full conversion, but never electively. Regardless of the access to the peritoneal cavity the course of LS was standardized. Patients were operated on in the right lateral decubitus position. At the beginning of all operations transection of the gastro-splenic ligament and short gastric vessels with various energy devices was performed. This was followed by extensive lateral mobilization of the spleen. There were however two different techniques of control of splenic vessels. At the beginning of our experience we used in all cases the technique referred to as "vessels first", described elsewhere \[[@cit0011], [@cit0012]\]. In this technique the main trunks of the splenic artery and vein were identified at the level of the pancreatic body/tail, isolated, clipped and transected. Than the entire splenic hilum including branches of all vessels, perivascular fat and lymphatic tissue was dissected away in one block from the pancreatic tail and removed together with the spleen ([Photo 1](#f0001){ref-type="fig"}). This approach does not require the use of a stapler, and because of its cost-effectiveness it was initially adopted for standard use during all LS. However, this technique has been mostly abandoned nowadays and is used only for patients with a particularly large caliber of splenic vessels, i.e. portal hypertension or splenomegaly.

![Laparoscopic splenectomy performed according to the "vessels first" approach. The entire splenic hilum is dissected together with the spleen from the pancreatic tail\
S -- spleen, H -- splenic hilum, P -- pancreas.](WIITM-13-32891-g001){#f0001}

Nowadays a different technique, referred to as "hilar transection", has been introduced. In this approach the main, nominate splenic vessels are not isolated. The entire splenic hilum is transected, as close as possible to the splenic parenchyma, with a new generation of energy devices -- Ligasure (Covidien) and more recently Thunderbeat (Olympus) ([Photo 2](#f0002){ref-type="fig"}). Both allow for safe closure of the vascular branches in the splenic hilum without use of staples. Occasionally some clips are applied on larger branches of vessels in the hilum, and the decision about their use belongs to the operating surgeon.

![Laparoscopic splenectomy performed according to the "hilar transection" approach. The splenic hilum is transected at the level of the splenic parenchyma with an energy device\
S -- spleen, H -- splenic hilum, P -- pancreas](WIITM-13-32891-g002){#f0002}

Ethics {#sec3.4}
------

The study was conducted according to the Report of the ISPOR Task Force on Retrospective Databases \[[@cit0013]\]. To ensure the quality of published studies that use health-related retrospective databases, a checklist that focuses on issues that are unique to database studies or are particularly problematic in database research was developed. Checklist questions cover a wide range of issues, including relevance, reliability and validity, data linkages, eligibility determination, research design, treatment effects, sample selection, censoring, variable definitions, resource valuation, statistical analysis, generalizability, and data interpretation. All procedures followed the ethical standards of the responsible committee on human experimentation (institutional and national) and the 2013, Fortaleza revision of the 1975 Declaration of Helsinki. The study was approved by an independent ethics committee of the Jagiellonian University, Krakow, Poland (approval number 1072/6120/160/2017). Informed consent for the surgical treatment was obtained from all patients before the procedure.

Statistical analysis {#sec3.5}
--------------------

All data were analyzed with StatSoft Statistica v.12.5 (StatSoft Inc, Tulsa, Oklahoma, USA). The results are presented as mean ± standard deviation (SD), median and interquartile range (IQR), when appropriate. The study of categorical variables used Pearson's χ^2^ test, or χ^2^ with Yates' correction, when appropriate. The Shapiro-Wilk test was used to check for normal distribution of data. Quantitative data were analyzed with Student's *t-*test (for normally distributed data) and the Mann-Whitney test (for non-normally distributed data). Results were considered statistically significant when the *p*-value was found to be less than 0.05.

Material {#sec3.6}
--------

In the period 1998--2017, we performed 545 laparoscopic operations of the spleen. The most common procedure was LS, which was performed in 487 patients. Seventy-two patients were excluded from the study group. The flow chart ([Figure 1](#f0003){ref-type="fig"}) presents the design of the study group in detail and reasons for exclusion. There were 188 patients included in group 1 ("vessels first"), and 287 in Group 2 ("hilar transection").

![Flowchart of patients through the study](WIITM-13-32891-g003){#f0003}

The study group consisted of 303 (63.79%) women and 172 (36.21%) men. The median age was 45 (15--84) years. The indications for splenectomy are presented in [Table I](#t0001){ref-type="table"}. The analyzed groups did not differ in demographics parameters. The details of data in both subgroups are presented in [Table II](#t0002){ref-type="table"}.

###### 

Indications for LS

  Indication                 Total         Group 1         Group 2                                  
  -------------------------- ------------- --------------- ------------ ------------- ------------- ------------------
  ITP                        254 (53.47)   11.5 (10--13)   99 (52.66)   11 (10--13)   155 (54.01)   12 (10--13)
  Lymphoma                   101 (21.26)   19 (17--23)     43 (22.88)   20 (18--27)   58 (20.21)    17 (15.5--20)
  Spherocytosis              32 (6.74)     17.5 (15--20)   15 (7.97)    18 (15--22)   17 (5.93)     17 (16--20)
  Autoimmune anemia          23 (4.84)     15 (14--17)     9 (4.79)     17 (15--17)   14 (4.88)     14 (12.5--17)
  Tumor                      20 (4.21)     14 (11--15.5)   1 (0.54)     17 (17--17)   19 (6.63)     14 (10--15)
  Splenomegaly               22 (4.63)     18 (16--20)     12 (6.38)    20 (18--30)   10 (3.48)     16.5 (15--18)
  Leukemia                   9 (1.89)      18 (17--22)     5 (2.66)     20 (17--25)   4 (1.39)      17.5 (14.75--20)
  Other:                     14 (2.95)     15 (12--20)     4 (2.13)     25 (20--35)   10 (3.48)     14.5 (11--15.5)
   Sarcoidosis               4                             0                          4             
   Splenic artery aneurysm   3                             1                          2             
   Osteomyelofibrosis        2                             2                          0             
   Splenic cyst              4                             0                          4             
   Gaucher disease           1                             1                          0             
  Total                      475 (100)     14 (11--17)     188          15 (11--20)   287           13 (11--17)

###### 

Patients' characteristics

  Parameter                    Group 1       Group 2       *P*-value
  ---------------------------- ------------- ------------- --------------------------------------
  Number of patients           188           287           --
  Age \[years\]:                                           0.001[^1^](#tf2-1){ref-type="fn"}
   Median                      40            50            
   IQR                         23--55.5      31--60        
   Range                       15--84        17--84        
  Female, *n* (%)              124 (65.96)   179 (62.37)   0.426[^2^](#tf2-2){ref-type="fn"}
  Male, *n* (%)                64 (34.04)    108 (37.63)   
  ASA 1, *n* (%)               43 (22.87)    68 (23.69)    0.804[^2^](#tf2-2){ref-type="fn"}
  ASA 2, *n* (%)               58 (30.85)    81 (28.22)    
  ASA 3, *n* (%)               49 (26.06)    85 (29.62)    
  ASA 4, *n* (%)               38 (20.21)    53 (18.47)    
  Size of the spleen \[cm\]:                               \< 0.001[^1^](#tf2-1){ref-type="fn"}
   Median                      15            13            
   IQR                         11--20        11--17        
   Range                       9--37         4--30         

Mann-Whitney test

Pearson's χ^2^ test.

Results {#sec4}
=======

The median operative time in the entire group was 100 (75--130) min. The median blood loss in the whole study was 50 ml (min.--max.: 0--1500; IQR: 20--150). A total of 34 patients required blood transfusion of 1--9 units of packed red blood cells. The overall conversion rate was 3.16%, and the intraoperative complication rate was 5.68%. Analysis of the parameters related to the course of the procedure included in the primary outcomes are presented in [Table III](#t0003){ref-type="table"}.

###### 

Analysis of intraoperative parameters in subgroups

  Parameter                               Group 1      Group 2     *P*-value
  --------------------------------------- ------------ ----------- --------------------------------------
  Operative time \[min\]:                                          \< 0.001[^1^](#tf3-1){ref-type="fn"}
   Median                                 135          90          
   IQR                                    100--160     70--120     
   Range                                  50--240      25--280     
  Intraoperative blood loss \[ml\]:                                \< 0.001[^1^](#tf3-1){ref-type="fn"}
   Median                                 100          50          
   IQR                                    50--400      20--100     
   Range                                  10--1200     0--1500     
  Need for blood transfusion, *n* (%)     19 (10.11)   15 (5.23)   0.044[^2^](#tf3-2){ref-type="fn"}
  Conversion, *n* (%)                     12 (6.38)    3 (1.05)    0.003[^3^](#tf3-3){ref-type="fn"}
  Intraoperative complications, *n* (%)   14 (7.45)    13 (4.53)   0.179[^2^](#tf3-2){ref-type="fn"}

Mann-Whitney test

Pearson's χ^2^ test

χ^2^ test with Yates' correction.

The average operative time in "hilar transection" group was shorter (135 min vs. 90 min respectively), and the difference was statistically significant (*p* \< 0.001). The median blood loss was also significantly lower in the same group (*p* \< 0.001). The conversion rate was higher in group 1 (6.38% vs. 1.05%). The difference was statistically significant (*p* = 0.003). There was no difference in the rate of intraoperative adverse events between study groups (*p* = 0.179). Most intraoperative adverse events were accidental injuries of various organs, which were repaired laparoscopically. The second most common group was massive bleeding, which required conversion in half of the cases. The number and types of intraoperative complications along with reasons for conversions in both study groups are listed in [Table IV](#t0004){ref-type="table"}.

###### 

Intraoperative adverse events and reasons for conversions

  Intraoperative adverse events                 Group 1       Group 2
  --------------------------------------------- ------------- -------------
  Accidental injury of intra-abdominal organ:                 
   Stomach                                      3 (1.59%)     1 (0.35%)
   Splenic flexure                              0             2 (0.69%)
   Diaphragm (sutured without chest tube)       2 (1.06%)     0
   Small bowel                                  0             1 (0.35%)
   Pancreatic tail                              0             1 (0.35%)
   Bladder (Pfannenstiel incision)              1 (0.53%)     0
  Massive bleeding:                                           
   Managed laparoscopically                     2 (1.06%)     4 (1.39%)
   Requiring conversion                         2 (1.06%)     3 (1.05%)
  Rupture of the retrieval bag                  4 (2.13%)     1 (0.35%)
  Total                                         14 (6.38%)    13 (4.53%)
  **Reasons for conversions**                   **Group 1**   **Group 2**
  Bleeding                                      2 (1.06%)     3 (1.05%)
  Technical problems                            4 (2.13%)     0
  Infiltration of surrounding structures        4 (2.13%)     0
  Spleen's friability                           1 (0.53%)     0
  Size of the spleen                            1 (0.53%)     0
  Total                                         12 (7.45%)    3 (1.05%)

Secondary outcomes reflecting safety of the procedure are listed in [Table V](#t0005){ref-type="table"}. Overall postoperative morbidity was 8.42% (40 patients) and we noted mortality of 0.21% (1 patient). This patient was operated on for massive splenomegaly caused by lymphoma. He was reoperated on classically 1 h after LS because of massive bleeding and again 2 h later for rebleeding with the need for CPR during surgery and eventually died in the intensive care unit (ICU).

###### 

Analysis of secondary outcomes in subgroups

  Outcome                                           Group 1       Group 2                             *P*-value
  ------------------------------------------------- ------------- ----------------------------------- -----------------------------------
  Postoperative morbidity                           21 (11.17%)   19 (6.62%)                          0.081[^1^](#tf5-1){ref-type="fn"}
  Complications related to injury of the pancreas   10 (5.32%)    4 (1.39%)                           0.028[^2^](#tf5-2){ref-type="fn"}
  Reoperation                                       8 (4.25%)     11 (3.83%)                          0.635[^2^](#tf5-2){ref-type="fn"}
  Mortality                                         0             1                                   --
  Length of stay \[days\]:                                        0.175[^3^](#tf5-3){ref-type="fn"}   
   Median                                           4             5                                   
   IQR                                              3--6          4--6                                
   Range                                            3--99         2--36                               

Pearson's χ^2^ test

χ^2^ test with Yates' correction

Mann-Whitney test.

There were more postoperative complications in the "vessels first" group (11.17% vs. 6.62%), but the difference was not significant (*p* = 0.081). However, the morbidity rate of complications attributed to accidental injury of the pancreatic parenchyma was significantly higher in group 1 (abscess or fluid collection in the splenic bed, pancreatitis, pancreatic fistula) (5.32% vs. 1.39%; *p* = 0.028). Classification of perioperative (≤ 30 days) complications according to the Clavien-Dindo classification is presented in [Table VI](#t0006){ref-type="table"}. Median length of hospital stay was 4 days (range: 1--99) and did not differ between study groups (*p* = 0.175).

###### 

Perioperative (≤ 30 days) complications according to Clavien-Dindo grading

  C-D                                                                                                                Complications                                                                                                                               Group 1       Group 2
  ------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------- ------------- ------------
  5                                                                                                                  Massive intraoperative blood loss. Reoperation for recurrent hemorrhage (patient death)                                                     0             1 (0.35%)
  4b                                                                                                                 Pancreatic fistula with abscess and secondary perforation of splenic flexure. Multiple reoperations. Cardiorespiratory failure (ICU stay)   1 (0.53%)     0
  3b                                                                                                                 Postoperative bleeding (relaparoscopy)                                                                                                      2 (1.06%)     4 (1.39%)
  Subphrenic abscess (reoperation)                                                                                   3 (1.59%)                                                                                                                                   2 (0.69%)     
  Acute pancreatitis (reoperation)                                                                                   1 (0.53%)                                                                                                                                   1 (0.35%)     
  Perforation of the fundus of the stomach probably due to thermal injury (reoperation on 8^th^ postoperative day)   0                                                                                                                                           1 (0.35%)     
  Subphrenic hematoma (operative drainage)                                                                           0                                                                                                                                           1 (0.35%)     
  Thrombosis of superior mesenteric artery (revascularization)                                                       0                                                                                                                                           1 (0.35%)     
  Pancreatic fistula                                                                                                 1 (0.53%)                                                                                                                                   0             
  3a                                                                                                                 Subphrenic abscess (percutaneous drainage)                                                                                                  1 (0.53%)     1 (0.35%)
  Port-site bleeding (suture ligation under local anesthesia)                                                        0                                                                                                                                           1 (0.35%)     
  Pelvic hematoma (percutaneous drainage)                                                                            1 (0.53%)                                                                                                                                   0             
  Pneumothorax (chest tube)                                                                                          0                                                                                                                                           1 (0.35%)     
  2                                                                                                                  Fever of unknown origin                                                                                                                     4 (2.13%)     3 (1.05%)
  Pulmonary infection                                                                                                1 (0.53%)                                                                                                                                   1 (0.35%)     
  Urinary tract infection                                                                                            1 (0.53%)                                                                                                                                   0             
  Superior mesenteric vein thrombosis                                                                                1 (0.53%)                                                                                                                                   0             
  Subphrenic hematoma                                                                                                0                                                                                                                                           1 (0.35%)     
  1                                                                                                                  Subphrenic fluid collection                                                                                                                 3 (1.59%)     0
  Pneumothorax (spontaneous resolution)                                                                              1 (0.53%)                                                                                                                                   0             
                                                                                                                     Total                                                                                                                                       21 (11.17%)   19 (6.62%)

Discussion {#sec5}
==========

In this study based on the analysis of outcomes of 475 laparoscopic splenectomies we were able to document that there are important differences in the postoperative outcome related to the technique of dissection and control of splenic vessels. The approach referred to as "hilar transection" in which vessels are transected practically at the level of the splenic parenchyma was associated with lower overall morbidity and significantly lower rates of local complications related most likely to accidental injury of the pancreatic tail. This method is, however, of limited use in patients with a large caliber of splenic vessels in portal hypertension or massive splenomegaly due to different causes, where the "vessels first" approach remains the technique of choice.

Currently there is no doubt that laparoscopy is the preferred approach for splenectomy. The benefits of this operation have been documented in many studies. The results are surprisingly good, and LS has become the standard approach for most elective operations. The numerous advantages of laparoscopy such as early recovery, lower postoperative pain, reduced surgical trauma and blood loss, lower complication rate and mortality, and better cosmetic effect have made it the method of choice in most centers \[[@cit0014]--[@cit0019]\]. Initially it was used only for cases expected to be easy and hassle-free, mainly idiopathic thrombocytopenic purpura (ITP) and hemolytic anemias with nonenlarged spleens \[[@cit0020], [@cit0021]\]. Later, growing experience allowed for safe use of this method even in difficult cases including massive splenomegaly \[[@cit0022]--[@cit0025]\]. Laparoscopic splenectomy may also be safely performed in patients at high risk of complications related to clotting disorders including end-stage thrombocytopenia \[[@cit0026], [@cit0027]\].

After more than a quarter of a century it is believed that the technique of LS is more or less standardized \[[@cit0028]--[@cit0030]\]. However, most reports do not concentrate on differences in the surgical technique, which in our opinion are crucial. There are publications that focus mostly on surgical access to the peritoneal cavity rather than the technique of dissection of the splenic hilum and control of the vascular pedicle of the spleen \[[@cit0009], [@cit0010], [@cit0031], [@cit0032]\]. In the technique referred to as "vessels first" the entire splenic hilum including branches of all vessels, perivascular fat and lymphatic tissue was dissected away in one block from the pancreatic tail and removed together with the spleen. The main benefit of this approach was cost-effectiveness as it did not require the use of a vascular stapler -- very popular in those times, but expensive. Even though economic issues are not analyzed in this paper, we believe that the "vessels first" technique was much less expensive and this aspect was most important for us in those times. We could document its feasibility and safety \[[@cit0011], [@cit0012]\]. With growing experience we found that it is related to relatively high incidence of various local complications including abscesses and fluid collections in the splenic bed, pancreatitis and pancreatic fistulas. We found evidence supporting this observation in the present study. The rate of those complications was almost twice as high in this group. This could be the result of dissection very close to the pancreatic parenchyma, which may cause direct injury, burns and ischemia of the pancreatic tail, leading to the abovementioned complications. Introduction of new generations of energy devices that allow for safe closure of relatively large vessels without clips resulted in a change in the operative approach. The dissection plane could be transferred from the pancreatic parenchyma to the splenic parenchyma. This allowed for protection of the pancreatic tail and resulted in a decrease in the risk of its injury. The reduction of local complications was documented in our study. There are more benefits of this technique. It is less time-consuming and is associated with lower blood loss and a lower conversion rate. The technique itself has some limitations. The caliber of vessels safely closed by energy devices is in the range 5--7 mm \[[@cit0033]--[@cit0035]\]. Usually in cases of non-enlarged spleens this is enough. However, sometimes, even in those cases, the diameter of branches in the splenic hilum, close to the splenic parenchyma, may be larger. There are two possible approaches to this situation. If those large-caliber vessels can be identified in the splenic hilum they can be individually clipped before transection. However, this technique may be difficult and time-consuming when numerous dilated branches are found, and this makes the procedure rather troublesome. We use a different method more frequently in cases when we expect to find larger vessels. In those patients the "vessels first" approach is still the primary technique, as it requires identification and isolation of only two vessels: the main trunks of the splenic artery and vein. Nowadays the "vessels first" technique is used mostly for difficult cases of large spleens or portal hypertension, which can explain, at least partially, the higher conversion rate in this group.

Our study has certain limitations typical for a single-center retrospective analysis. There is a potential bias regarding the use of postoperative drainage. At the beginning we routinely introduced at least one drain after each splenectomy. Later we stopped this practice, limiting the use of drains to complicated cases, for example involving injuries of the pancreatic tail \[[@cit0036]\]. The drains are known to be directly related to the occurrence of surgical site infections, and the difference in the rate of those complication is one of the most important results of the current study. Unfortunately, there is a lack of reliable data concerning recent use of drains, and we could not include this parameter in our analysis. Another limitation is the fact that in this analysis we did not include potential postoperative complications that might have occurred later than 30 days after discharge. This could certainly influence the overall complication rate.

Conclusions {#sec6}
===========

Postoperative outcome after LS is related to the technique of dissection and control of the splenic vascular pedicle. The "vessels first" technique is associated with longer operative time, higher blood loss and increased risk of conversion. The approach referred to as "hilar transection" is associated with lower incidence of local complications related most likely to accidental injury of the pancreatic tail. All those data favor the latter method, although in the case of a large caliber of splenic vessels the "vessels first" approach remains the technique of choice.
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